Hot Keywords
Tumor Microenvironment Exosomes and Extracellular Vesicles Breast Cancer Metastasis Bone Metastasis Metastatic Renal Cell Carcinoma Lymph node metastasis Mesothelioma Hematological Malignancies Thyroid Cancer Liquid Biopsies Early Diagnosis Lung Cancer Brain Tumors Lymphoma Oncolytic Virus Cervical Cancer Cancer Stem Cells

Topic: Primary and Secondary Brain Tumors

A special issue of Journal of Cancer Metastasis and Treatment

ISSN 2454-2857 (Online), ISSN 2394-4722 (Print)

Submission deadline: 31 Jan 2021

Guest Editor(s)

  • Dr. Lombardi Giuseppe
    Department of Experimental and Clinical Oncology, Medical Oncology 1, Veneto Institute of Oncology-IRCCS, Padua, Italy.

    Website | E-mail

  • Dr. Bellu Luisa
    Radiotherapy Department, Radiotherapist at Veneto Institute of Oncology-IRCCS, Padua, Italy.


  • Dr. Ius Tamara
    Neurosurgery Unit, Department of Neurosciences, Santa Maria della Misericordia Univeristy Hospital, Udine, Italy.


  • Dr. Villani Veronica
    Neurology Department, Neurologists at Regina Elena Hospital, Rome, Italy.


  • Dr. Caccese Mario
    Oncology Department, Veneto Institute of Oncology-IRCCS, Padua, Italy.


Special Issue Introduction

Primary tumors are a heterogenous group of neoplasms originating from brain. Since 2016 we have had the new WHO classification incorporating new molecular characteristics, in particular IDH mutational status and 1p19q codeletion. Glioblastoma represents the most frequent primary brain tumor in adults and numerous studies were performed analyzing new treatments, such as regorafenib showing interesting results. Moreover, we have new approaches for radiotherapy and neurosurgery. New approaches for magnetic resonance imaging and positron emission tomography are integrated into diagnostic and follow up steps. Low grade gliomas and other primary and secondary brain tumors such as meningiomas or lung or melanoma metastases showed interesting responses to new treatment, in particular to combination of radiotherapy, immunotherapy and targeted therapy.This special issue will cover all aspects of primary and secondary brain tumors including current treatment options, radiation therapy, surgery, immunotherapy, imaging and molecular characteristics. Reviews will also be gratefully accepted.


Brain tumors, immunotherapy, brain metastases, glioblastoma

Submission Deadline

31 Jan 2021

Submission Information

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to
For Online Submission, please login at
Submission Deadline: 31 Jan 2021
Contacts: Ivory Ma, Assistant Editor,

Published Articles

© 2016-2023 OAE Publishing Inc., except certain content provided by third parties